Healthcare IT News November 12, 2021
Rachel McArthur

The collaboration between the UAE capital’s Department of Health and Novartis will be dedicated to cardiovascular diseases – a leading cause of death in the Gulf nation.

Abu Dhabi’s Department of Health (DoH) has confirmed it has become the first healthcare regulator in the Middle East region – and the second in the world – to explore and adopt a Population Health Model (PHM). The model, which is being developed in collaboration with Switzerland’s Novartis, will be dedicated to cardiovascular diseases (CVDs), focusing on early detection, management, and prevention, the DoH announced.

“CVD is a major cause of death, hospitalisation, and low quality of life among patients. Therefore, it has become a key priority for the healthcare institutes in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Healthcare System, Population Health Mgmt, Provider
Related Articles:
Longitude Health launches population health company
Systems Thinking: The Future of Equitable, Efficient, and Effective Population Health Management
Growing Demand for Population Health Tools in Asia-Pacific Highlighted in the 2025 Black Book of Global Healthcare IT
Alzheimer Disease Treatment Can Improve Population Health and Health Equity
Designing and Evaluating Interventions that have a Measurable Impact on Population Health through Evidence-Based Practices and Research

Share This Article